Key result
Higher lipid accumulation product linked to ~32% higher odds of hypertension in nondiabetic adults.
Why the study?
Risk factors for hypertension and prehypertension needed assessment to clarify the role of lipid accumulation product in the development of hypertension among nondiabetic individuals.
Is a higher lipid accumulation product (LAP) and its interaction with family history of hypertension associated with increased prevalence of hypertension and prehypertension in nondiabetic middle-aged and older adults in eastern China?
Cross-Sectional (n=7,733)
Yes
Is a higher lipid accumulation product (LAP) and its interaction with family history of hypertension associated with increased prevalence of hypertension and prehypertension in nondiabetic middle-aged and older adults in eastern China?
Lipid accumulation product (LAP) is an independent predictor of hypertension that outperforms BMI and WHtR in discriminative ability and interacts synergistically with a family history of hypertension in nondiabetic Chinese adults.
Answers are grounded in this paper and cite their sources.
LAP may support hypertension risk assessment in nondiabetic adults; leaves open prospective validation before clinical adoption.
This study was aimed at assessing the risk factors for hypertension (HTN) and prehypertension (PHT) in order to clarify the role of lipid accumulation product (LAP) in the development of HTN among nondiabetic individuals. A large cross-sectional study was conducted in community health service centers in urban Bengbu, Anhui Province, China. All participants completed an interview questionnaire and procedures to obtain physical measurements and biochemical indicators. Multivariate logistic regression was used to test for the prevalence of HTN and PHT in relation to each quartile increase in LAP level and family history of HTN. The resulting interaction effects were evaluated by relative excess risk of interaction (RERI), attributable proportion due to interaction (AP), and synergy index (SI). A total of 7733 subjects were enrolled in the study. The overall prevalence rates of PHT and HTN were 37.1% and 24.8%, respectively. After adjusting for confounding factors, multinomial logistic regression analysis showed that compared with subjects in LAP quartile 1, those in quartile 3 (OR, 1.257; 95% CI, 1.062-1.494) and quartile 4 (OR, 1.323; 95% CI, 1.101-1.592) had a significantly higher risk for HTN (p for trend < .001). A significant interaction was observed between LAP and family history of HTN in men (AP, 0.1661; 95% CI, 0.0024-0.3296; SI, 1.4037; 95% CI, 1.0599-1.8593) and in women (RERI, 1.4111; 95% CI, 0.1458-2.9678; AP, 0.1662; 95% CI, 0.0085-0.3237; SI, 1.3886; 95% CI, 1.0568-1.8247). The results demonstrated that the interactive effects of LAP with family history of HTN may influence the development of HTN synergistically.
No takes yet. Share an insight, caveat, or question.
Shu et al. (2023) conducted a cross-sectional in Hypertension and prehypertension among nondiabetic adults (n=7,733). Higher lipid accumulation product (LAP quartile 4 vs quartile 1) vs. Lowest lipid accumulation product quartile (LAP quartile 1) was evaluated on Prevalence of hypertension (SBP ≥140 mmHg and/or DBP ≥90 mmHg or previously diagnosed HTN) (OR 1.323, 95% CI 1.101-1.592, p=< .001 for trend). Higher lipid accumulation product (quartile 4 vs quartile 1) was associated with increased odds of hypertension in nondiabetic adults.
Synapse has enriched 10 related papers. Consider them for comparative context: